Stay updated on DSP-5336 in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DSP-5336 in Relapsed AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    - Added Horizon-1 Phase 1/2 study of Enzomenib (DSP-5336) in acute leukemia with multiple arms, SOC combinations, and a detailed global site list. Replaced the former DSP-5336 relapsed/refractory AML/ALL study description with the Horizon-1 protocol and expanded indications and design.
    Difference
    8%
    Check dated 2026-03-28T13:44:52.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:39:32.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible content changes.
    Difference
    0.0%
    Check dated 2026-03-06T18:39:41.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; Deleted Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:33:23.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Minor revision update from v3.4.0 to v3.4.1; no impact on content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:18:19.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 in the page footer. No study details, eligibility, contacts, or locations were altered.
    Difference
    0.0%
    Check dated 2026-01-15T03:07:01.000Z thumbnail image

Stay in the know with updates to DSP-5336 in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.